A detailed history of Sym Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sym Financial Corp holds 7,538 shares of BMY stock, worth $352,853. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,538
Previous 8,585 12.2%
Holding current value
$352,853
Previous $397,000 14.61%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$43.31 - $48.98 $45,345 - $51,282
-1,047 Reduced 12.2%
7,538 $339,000
Q2 2025

Aug 01, 2025

SELL
$44.12 - $59.6 $13,544 - $18,297
-307 Reduced 3.45%
8,585 $397,000
Q1 2025

May 06, 2025

SELL
$53.9 - $63.11 $10,672 - $12,495
-198 Reduced 2.18%
8,892 $542,000
Q4 2024

Jan 24, 2025

BUY
$51.92 - $59.94 $69,988 - $80,799
1,348 Added 17.41%
9,090 $514,000
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $20,702 - $27,013
-522 Reduced 6.32%
7,742 $400,000
Q2 2024

Aug 08, 2024

BUY
$40.25 - $52.99 $332,626 - $437,909
8,264 New
8,264 $343,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sym Financial Corp Portfolio

Follow Sym Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sym Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sym Financial Corp with notifications on news.